These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 15919438

  • 1. Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting.
    Muzi F, Orlando G, Ielpo B, Anselmo A, Sabato Ceraldi S, de Liguori Carino N, Manzia T, D'Andria D, Tariciotti L, Angelico M, Tisone G.
    Transplant Proc; 2005 May; 37(4):1705-7. PubMed ID: 15919438
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amantadine therapy in renal transplant patients with hepatitis C virus infection.
    Kamar N, Rostaing L, Sandres-Saune K, Ribes D, Durand D, Izopet J.
    J Clin Virol; 2004 May; 30(1):110-4. PubMed ID: 15072764
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N, Shiffman ML, Stravitz RT, Sterling RK, Luketic VA, Sanyal AJ, Mills AS, Contos MJ, Coterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [Abstract] [Full Text] [Related]

  • 6. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 7. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.
    Khettry U, Huang WY, Simpson MA, Pomfret EA, Pomposelli JJ, Lewis WD, Jenkins RL, Gordon FD.
    Hum Pathol; 2007 Mar; 38(3):443-52. PubMed ID: 17188331
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatitis C virus recurrence after liver transplantation: influence of immunosuppressive regimens on viral load and liver histology.
    Oton E, Barcena R, Castillo M, Barreales M, Blesa C, Moreno-Planas JM, Barrios C, Garrido A, Cuervas V.
    Transplant Proc; 2006 Oct; 38(8):2499-501. PubMed ID: 17097980
    [Abstract] [Full Text] [Related]

  • 13. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Oct; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 14. Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C.
    Ciccorossi P, Maina AM, Oliveri F, Petruccelli S, Leandro G, Colombatto P, Moriconi F, Mosca F, Filipponi F, Bonino F, Brunetto MR.
    Liver Int; 2007 Jun; 27(5):612-9. PubMed ID: 17498245
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
    Cescon M, Grazi GL, Cucchetti A, Vetrone G, Ravaioli M, Ercolani G, Morelli MC, Piscaglia F, Tamè M, Pinna AD.
    Liver Transpl; 2009 Jul; 15(7):782-9. PubMed ID: 19562715
    [Abstract] [Full Text] [Related]

  • 17. A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.
    Margarit C, Bilbao I, Castells L, Lopez I, Pou L, Allende E, Escartin A.
    Transpl Int; 2005 Dec; 18(12):1336-45. PubMed ID: 16297052
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
    Walter T, Dumortier J, Guillaud O, Hervieu V, Scoazec JY, Boillot O.
    Liver Transpl; 2007 Feb; 13(2):294-301. PubMed ID: 17256784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.